Drug intelligence / Profile preview

jinshuangqi

Development stage: Unknown
Lead developer: Inner Mongolia Shuangqi Pharmaceutical
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

Jinshuangqi (金双歧) is a probiotic formulation used in China, primarily as a dietary supplement. It contains beneficial bacteria intended to modulate the gut microbiota and improve gastrointestinal health. Clinical studies have investigated its effects on lipid metabolism in critically ill patients, showing that Jinshuangqi can significantly reduce triglyceride levels and influence HDL-C values. The mechanism is thought to involve the production of lipase by probiotics, which helps break down triglycerides into more digestible substrates. Jinshuangqi is often compared with or combined with probiotic yogurt for metabolic benefits[5][10].

Brand names: jinshuangqi金双歧
Other names: 金双歧益生菌制剂

Beyond the preview

Go deeper on jinshuangqi.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on jinshuangqi.

Explore the full profile